Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosisT C Nichols, D A Bellinger, D A Tate, et al.Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimerasT C Nichols, C M Samama, D A Bellinger, et al.Science (New York, N.Y.)|October 1, 1993
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogsM A Kay, S Rothenberg, C N Landen, et al.Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 25, 2002
Splenic clearance mechanisms of rehydrated, lyophilized plateletsT H Fischer, E Merricks, D A Bellinger, et al.Human Gene Therapy|August 1, 1995
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expressionB Fang, R C Eisensmith, H Wang, et al.Blood|May 15, 1993
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia AT C Nichols, D A Bellinger, R L Reddick, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 1998
von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stressT C Nichols, D A Bellinger, R L Reddick, et al.AJR. American Journal of Roentgenology|December 1, 1982
Diode array digital radiography: initial clinical experienceD Sashin, E J Sternglass, B S Slasky, et al.The American Journal of Clinical Nutrition|July 1, 1988
Cross-sectional study of nutrition knowledge and attitudes of medical students at three points in their medical training at 11 southeastern medical schoolsR L Weinsier, J R Boker, S L Morgan, et al.Thrombosis and Haemostasis|April 20, 2001
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogsK E Russell, M S Read, D A Bellinger, et al.Pageof 13